ArticleLeukemia2024
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax.
Anudishi Tyagi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it